findmyKOL
Clinical trialNCT07433660RecruitingObservational

WellSpan-THRIVE Cancer QOL Study

SponsorWellSpan HealthEnrollment1,000Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or PalliativeCancer (Advanced Stage)Cancer (Solid Tumors)Cancer (With or Without Metastasis)Cancer - OvarianCancer Abdomen
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Wellspan Medical Oncology & Hematology

    Chambersburg, Pennsylvania, United States

    Recruiting
  • Wellspan Ephrata Cancer Center

    Ephrata, Pennsylvania, United States

    Recruiting
  • Wellspan Adams Cancer Center

    Gettysburg, Pennsylvania, United States

    Recruiting
  • Wellspan Sechler Family Cancer Center

    Lebanon, Pennsylvania, United States

    Recruiting
  • Wellspan York Cancer Center

    York, Pennsylvania, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2026
Primary completion
28 Feb 2031
Completion
31 Dec 2031
Last update posted
2 Mar 2026
Registered enrollment
1,000
Registry id
NCT07433660

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.